Sulfotransferases and sulfated oligosaccharides

Medicinal Research Reviews

Volumn 22, Issue 6, 2002, Pages 637-654

  Honke, Koichi ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Oligosaccharides; Sulfotransferases

Indexed keywords

ADENOSINE 3' PHOSPHATE 5' PHOSPHOSULFATE; ADENYLYLSULFATE KINASE; CHONDROITIN SULFATE; DERMATAN SULFATE; GLYCOLIPID; GLYCOPROTEIN; GLYCOSAMINOGLYCAN; GLYCOSYLTRANSFERASE; HEPARAN SULFATE; HEPARIN; KERATAN SULFATE; LUTEINIZING HORMONE; OLIGOSACCHARIDE; PROOPIOMELANOCORTIN; PROTEOGLYCAN; SELECTIN; SULFATE ADENYLYLTRANSFERASE; SULFATIDE; SULFOTRANSFERASE; THYROTROPIN;

CANCER; CARBOHYDRATE ANALYSIS; CATALYST; DRUG TARGETING; GENETIC DISORDER; GOLGI COMPLEX; HUMAN; INFECTION; INFLAMMATION; MOLECULAR RECOGNITION; NONHUMAN; REVIEW; SULFATION;

ANIMALS; CARBOHYDRATE SEQUENCE; CHONDROITIN SULFATES; DERMATAN SULFATE; EPITOPES; GLYCOLIPIDS; GLYCOPROTEINS; GLYCOSAMINOGLYCANS; HEPARIN; HEPARITIN SULFATE; HUMANS; KERATAN SULFATE; MOLECULAR SEQUENCE DATA; OLIGOSACCHARIDES; PITUITARY HORMONES; PROTEOGLYCANS; STRUCTURE-ACTIVITY RELATIONSHIP; SULFATES; SULFOTRANSFERASES;

EID: 0036846183     PISSN: 01986325     EISSN: None     Source Type: Journal    
DOI: 10.1002/med.10020     Document Type: Review

References (141)

1. Hastbacka J, de la Chapelle A, Mahtani MM, Clines G, Reeve-Daly MP, Daly M, Hamilton BA, Kusumi K, Trivedi B, Weaver A, Coloma A, Lovett M, Buckler A, Kaitila I, Lander ES. The diastrophic dysplasia gene encodes a novel sulfate transporter: Positional cloning by fine-structure linkage disequilibrium mapping. Cell 1994;78:1073-1087.
2. Kurima K, Warman ML, Krishnan S, Domowicz M, Krueger RC, Jr, Deyrup A, Schwartz NB. A member of a family of sulfate-activating enzymes causes murine brachymorphism. Proc Natl Acad Sci USA 1998;95:8681-8685.
3. Superti-Furga, A. A defect in the metabolic activation of sulfate in a patient with achondrogenesis type IB. Am J Hum Genet 1994;55:1137-1145.
4. Brandan E, Hirschberg CB. Purification of rat liver N-heparan-sulfate sulfotransferase. J Biol Chem 1988;263:2417-2422.
5. Hashimoto Y, Orellana A, Gil G, Hirschberg CB. Molecular cloning and expression of rat liver N-heparan sulfate sulfotransferase. J Biol Chem 1992;267:15744-15750.
6. Bakker H, Friedmann I, Oka S, Kawasaki T, Nifant'ev N, Schachner M, Mantei N. Expression cloning of a cDNA encoding a sulfotransferase involved in the biosynthesis of the HNK-1 carbohydrate epitope. J Biol Chem;272:29942-29946.
7. Fukuta M, Uchimura K, Nakashima K, Kato M, Kimata K, Shinomura T, Habuchi O. Molecular cloning and expression of chick chondrocyte chondroitin 6-sulfotransferase. J Biol Chem 1995;270:18575-18580.
8. Fukuta M, Inazawa J, Torii T, Tsuzuki K, Shimada E, Habuchi O. Molecular cloning and characterization of human keratan sulfate Gal-6-sulfotransferase. J Biol Chem 1997;272:32321-32328.
9. Uchimura K, Muramatsu H, Kadomatsu K, Fan QW, Kurosawa N, Mitsuoka C, Kannagi R, Habuchi O, Muramatsu T. Molecular cloning and characterization of an N-acetylglucosamine-6-O-sulfotransferase. J Biol Chem 1998;273:22577-22583.
10. Bistrup A, Bhakta S, Lee JK, Belov YY, Gunn MD, Zuo FR, Huang CC, Kannagi R, Rosen SD, Hemmerich S. Sulfotransferases of two specificities function in the reconstitution of high endothelial cell ligands for L-selectin. J Cell Biol 1999;145:899-910.
11. x, an L-selectin ligand displayed by CD34. Immunity 1999;11:79-89.
12. Lee JK, Bhakta S, Rosen SD, Hemmerich S. Cloning and characterization of a mammalian N-acetylglucosamine-6-sulfotransferase that is highly restricted to intestinal tissue. Biochem Biophys Res Commun 1999;263:543-549.
13. Honke K, Yamane M, Ishii A, Kobayashi T, Makita A. Purification and characterization of 3′-phosphoadenosine-5′-phosphosulfate:GalCer sulfotransferase from human renal cancer cells. J Biochem 1996;119:421-427.
14. Honke K, Tsuda M, Koyota S, Wada Y, Tanaka N, Ishizuka I, Nakayama J, Taniguchi N. Molecular cloning and characterization of a human β-Gal-3′-sulfotransferase that acts on both type 1 and type 2 (Gal β1-3/1-4GlcNAc-R) oligosaccharides. J Biol Chem 2001;276:267-274.
15. Hirahara Y, Tsuda M, Wada Y, Honke K. cDNA cloning, genomic cloning, and tissue-specific regulation of mouse cerebroside sulfotransferase. Eur J Biochem 2000;267:1909-1916.
16. Akama TO, Nishida K, Nakayama J, Watanabe H, Ozaki K, Nakamura T, Dola A, Kawasaki S, Inoue Y, Maeda N, Yamamoto S, Fujiwara T, Thonar EJ, Shimomura Y, Kinoshita S, Tanigami A, Fukuda MN. Macular corneal dystrophy type I and type II are caused by distinct mutations in a new sulphotransferase gene. Nat Genet;2000;262(2):237-241.
17. Pinhal MA, Smith B, Olson S, Aikawa J, Kimata K, Esko JD. Enzyme interactions in heparan sulfate biosynthesis: Uronosyl 5-epimerase and 2-O-sulfotransferase interact in vivo. Proc Natl Acad Sci USA 2001;98:12984-12989.
18. Kakuta Y, Sueyoshi T, Negishi M, Pedersen LC. Crystal structure of the sulfotransferase domain of human heparan sulfate N-deacetylase/N-sulfotransferase 1. J Biol Chem 1999;274:10673-10676.
19. Kakuta Y, Pedersen LG, Carter CW, Negishi M, Pedersen LC. Crystal structure of estrogen sulphotransferase. Nat Struct Biol 1997;4:904-908.
20. Kakuta Y, Pedersen LG, Pedersen LC, Negishi M. Conserved structural motifs in the sulfotransferase family. Trends Biochem Sci 1998;23:129-130.
21. Sueyoshi T, Kakuta Y, Pedersen LC, Wall FE, Pedersen LG, Negishi M. A role of Lys614 in the sulfotransferase activity of human heparan sulfate N-deacetylase/N-sulfotransferase. FEBS Lett 1998;433:211-214.
22. Ong E, Yeh JC, Ding Y, Hindsgaul O, Pedersen LC, Negishi M, Fukuda M. Structure and function of HNK-1 sulfotransferase. Identification of donor and acceptor binding sites by site-directed mutagenesis. J Biol Chem 1999;274:25608-25612.
23. Kamio K, Honke K, Makita A. Pyridoxal 5′-phosphate binds to a lysine residue in the adenosine 3′-phosphate 5′-phosphosulfate recognition site of glycolipid sulfotransferase from human renal cancer cells. Glycoconj J 1995;12:762-766.
24. Yabe T, Shukla D, Spear PG, Rosenberg RD, Seeberger PH, Shworak NW. Portable sulphotransferase domain determines sequence specificity of heparan sulphate 3-O-sulphotransferases. Biochem J 2001;359:235-241.
25. Raman R, Myette J, Venkataraman G, Sasisekharan V, Sasisekharan R. Identification of structural motifs and amino acids within the structure of human heparan sulfate 3-O-sulfotransferase that mediate enzymatic function. Biochem Biophys Res Commun 2002;290:1214-1219.
26. Selleck SB. Genetic dissection of proteoglycan function in Drosophila and C. elegans. Semin Cell Dev Biol 2001;12:127-134.
27. Rogerson SJ, Chaiyaroj SC, Ng K, Reeder JC, Brown GV. Chondroitin sulfate A is a cell surface receptor for Plasmodium falciparum-infected erythrocytes. J Exp Med 1995;182:15-20.
28. Fried M, Duffy PE. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 1996;272:1502-1504.
29. Naujokas MF, Morin M, Anderson MS, Peterson M, Miller J. The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell 1993;74:257-268.
30. Toyama-Sorimachi N, Sorimachi H, Tobita Y, Kitamura F, Yagita H, Suzuki K, Miyasaka M. A novel ligand for CD44 is serglycin, a hematopoietic cell lineage-specific proteoglycan. Possible involvement in lymphoid cell adherence and activation. J Biol Chem 1995;270:7437-7444.
31. Yamagata M, Suzuki S, Akiyama SK, Yamada KM, Kimata K. Regulation of cell-substrate adhesion by proteoglycans immobilized on extracellular substrates. J Biol Chem 1989;264:8012-8018.
32. Sugiura N, Sakurai K, Hori Y, Karasawa K, Suzuki S, Kimata K. Preparation of lipid-derivatized glycosaminoglycans to probe a regulatory function of the carbohydrate moieties of proteoglycans in cell-matrix interaction. J Biol Chem 1993;268:15779-15787.
33. Albertini R, De Luca G, Passi A, Moratti R, Abuja PM. Chondroitin-4-sulfate protects high-density lipoprotein against copper-dependent oxidation. Arch Biochem Biophys 1999;365:143-149.
34. Yamauchi S, Mita S, Matsubara T, Fukuta M, Habuchi H, Kimata K, Habuchi O. Molecular cloning and expression of chondroitin 4-sulfotransferase. J Biol Chem 2000;275:8975-8981.
35. Hiraoka N, Nakagawa H, Ong E, Akama TO, Fukuda MN, Fukuda M. Molecular cloning and expression of two distinct human chondroitin 4-O-sulfotransferases that belong to the HNK-1 sulfotransferase gene family. J Biol Chem 2000;275:20188-20196.
36. Yamauchi S, Hirahara Y, Usui H, Takeda Y, Hoshino M, Fukuta M, Kimura JH, Habuchi O. Purification and characterization of chondroitin 4-sulfotransferase from the culture medium of a rat chondrosarcoma cell line. J Biol Chem 1999;274:2456-2463.
37. Evers MR, Xia G, Kang HG, Schachner M, Baenziger JU. Molecular cloning and characterization of a dermatan-specific N-acetylgalactosamine 4-O-sulfotransferase. J Biol Chem 2001;276:36344-36353.
38. Maeda N, Nishiwaki T, Shintani T, Hamanaka H, Noda M. 6B4 proteoglycan/phosphacan, an extracellular variant of receptor-like protein-tyrosine phosphataseζ/RPTPβ, binds pleiotrophin/heparin-binding growth-associated molecule (HB-GAM). J Biol Chem 1996;271:21446-21452.
39. Maeda N, Ichihara-Tanaka K, Kimura T, Kadomatsu K, Muramatsu T, Noda M. A receptor-like protein-tyrosine phosphatase PTPζ/RPTPβ binds a heparin-binding growth factor midkine. Involvement of arginine 78 of midkine in the high affinity binding to PTPζ. J Biol Chem 1999;274:12474-12479.
40. Habuchi O, Hirahara Y, Uchimura K, Fukuta M. Enzymatic sulfation of galactose residue of keratan sulfate by chondroitin 6-sulfotransferase. Glycobiology 1996;6:51-57.
41. Habuchi O, Suzuki Y, Fukuta M. Sulfation of sialyl lactosamine oligosaccharides by chondroitin 6-sulfotransferase. Glycobiology 1997;7:405-412.
42. Uchimura K, Kadomatsu K, Nishimura H, Muramatsu H, Nakamura E, Kurosawa N, Habuchi O, El-Fasakhany FM, Yoshikai Y, Muramatsu T. Functional analysis of the chondroitin 6-sulfotransferase gene in relation to lymphocyte subpopulations, brain development, and oversulfated chondroitin sulfates. J Biol Chem 2002;277:1443-1450.
43. Ohtake S, Ito Y, Fukuta M, Habuchi O. Human N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase cDNA is related to human B cell recombination activating gene-associated gene. J Biol Chem 2001;276:43894-43900.
44. Ito Y, Habuchi O. Purification and characterization of N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase from the squid cartilage. J Biol Chem 2000;275:34728-34736.
45. Kobayashi M, Sugumaran G, Liu J, Shworak NW, Silbert JE, Rosenberg RD. Molecular cloning and characterization of a human uronyl 2-sulfotransferase that sulfates iduronyl and glucuronyl residues in dermatan/chondroitin sulfate. J Biol Chem 1999;274:10474-10480.
46. Penc SF, Pomahac B, Eriksson E, Detmar M, Gallo RL. Dermatan sulfate activates nuclear factor-κb and induces endothelial and circulating intercellular adhesion molecule-1. J Clin Invest 1999;103:1329-1335.
47. Turnbull JE, Fernig DG, Ke Y, Wilkinson MC, Gallagher JT. Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. J Biol Chem 1992;267:10337-10341.
48. Maimone MM, Tollefsen DM. Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity. J Biol Chem 1990;265:18263-18271.
49. Park PW, Pier GB, Hinkes MT, Bernfield M. Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence. Nature 2001;411:98-102.
50. Wei Z, Swiedler SJ, Ishihara M, Orellana A, Hirschberg CB. A single protein catalyzes both N-deacetylation and N-sulfation during the biosynthesis of heparan sulfate. Proc Natl Acad Sci USA 1993;90:3885-3888.
51. Pettersson I, Kusche M, Unger E, Wlad H, Nylund L, Lindahl U, Kjellen L. Biosynthesis of heparin. Purification of a 110-kDa mouse mastocytoma protein required for both glucosaminyl N-deacetylation and N-sulfation. J Biol Chem 1991;266:8044-8049.
52. Oellana A, Hirschberg CB, Wei Z, Swiedler SJ, Ishihara M. Molecular cloning and expression of a glycosaminoglycan N-acetylglucosaminyl N-deacetylase/N-sulfotransferase from a heparin-producing cell line. J Biol Chem 1994;269:2270-2276.
53. Eriksson I, Sandback D, Ek B, Lindahl U, Kjellen L. cDNA cloning and sequencing of mouse mastocytoma glucosaminyl N-deacetylase/N-sulfotransferase, an enzyme involved in the biosynthesis of heparin. J Biol Chem 1994;269:10438-10443.
54. Aikawa J, Esko JD. Molecular cloning and expression of a third member of the heparan sulfate/heparin GlcNAc N-deacetylase/N-sulfotransferase family. J Biol Chem 1999;274:2690-2695.
55. Aikawa J, Grobe K, Tsujimoto M, Esko JD. Multiple isozymes of heparan sulfate/heparin GlcNAc N-deacetylase/GlcN N-sulfotransferase. Structure and activity of the fourth member, NDST4. J Biol Chem 2001;276:5876-5882.
56. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999;68:729-777.
57. Fan G, Xiao L, Cheng L, Wang X, Sun B, Hu G. Targeted disruption of NDST-1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice. FEBS Lett 2000;467:7-11.
58. Ringvall M, Ledin J, Holmborn K, van Kuppevelt T, Ellin F, Eriksson I, Olofsson AM, Kjellen L, Forsberg E. Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/N-sulfotransferase-1. J Biol Chem 2000;275:25926-25930.
59. Perrimon N, Bernfield M. Specificities of heparan sulphate proteoglycans in developmental processes. Nature 2000;404:725-728.
60. Lin X, Perrimon N. Dally cooperates with Drosophila Frizzled 2 to transduce Wingless signalling. Nature 1999;400:281-284.
61. Tsuda M, Kamimura K, Nakato H, Archer M, Staatz W, Fox B, Humphrey M, Olson S, Futch T, Kaluza V, Siegfried E, Stam L, Selleck SB. The cell-surface proteoglycan Dally regulates Wingless signalling in Drosophila. Nature 1999;400:276-280.
62. Lin X, Buff EM, Perrimon N, Michelson AM. Heparan sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development. Development 1999;126:3715-3723.
63. Kusche-Gullberg M, Eriksson I, Pikas DS, Kjellen L. Identification and expression in mouse of two heparan sulfate glucosaminyl N-deacetylase/N-sulfotransferase genes. J Biol Chem 1998;273:11902-11907.
64. Toma L, Berninsone P, Hirschberg CB. The putative heparin-specific N-acetylglucosaminyl N-deacetylase/N-sulfotransferase also occurs in non-heparin-producing cells. J Biol Chem 1998;273:22458-22465.
65. Forsberg E, Pejler G, Ringvall M, Lunderius C, Tomasini-Johansson B, Kusche-Gullberg M, Eriksson I, Ledin J, Hellman L, Kjellen L. Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature 1999;400:773-776.
66. Humphries DE, Wong GW, Friend DS, Gurish MF, Qiu WT, Huang C, Sharpe AH, Stevens RL. Heparin is essential for the storage of specific granule proteases in mast cells. Nature 1999;400:769-772.
67. Maccarana M, Casu B, Lindahl U. Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J Biol Chem 1993;268:23898-23905.
68. Faham S, Hileman RE, Fromm JR, Linhardt RJ, Rees DC. Heparin structure and interactions with basic fibroblast growth factor. Science 1996;271:1116-1120.
69. Guimond S, Maccarana M, Olwin BB, Lindahl U, Rapraeger AC. Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. J Biol Chem 1993;268:23906-23914.
70. DiGabriele AD, Lax I, Chen DI, Svahn CM, Jaye M, Schlessinger J, Hendrickson WA. Structure of a heparin-linked biologically active dimer of fibroblast growth factor. Nature 1998;393:812-817.
71. Pye DA, Vives RR, Turnbull JE, Hyde P, Gallagher JT. Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity. J Biol Chem 1998;273:22936-22942.
72. Sen J, Goltz JS, Stevens L, Stein D. Spatially restricted expression of pipe in the Drosophila egg chamber defines embryonic dorsal-ventral polarity. Cell 1998;95:471-481.
73. Bullock SL, Fletcher JM, Beddington RS, Wilson VA. Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase. Genes Dev 1998;12:1894-1906.
74. -/- mutant mouse. J Biol Chem 2001;276:354279-35434.
75. Lyon M, Deakin JA, Mizuno K, Nakamura T, Gallagher JT. Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants. J Biol Chem 1994;269:11216-11223.
76. Ashikari S, Habuchi H, Kimata K. Characterization of heparan sulfate oligosaccharides that bind to hepatocyte growth factor. J Biol Chem 1995;270:29586-29593.
77. Lindahl B, Lindahl U. Amyloid-specific heparan sulfate from human liver and spleen. J Biol Chem 1997;272:26091-26094.
78. Jayson GC, Lyon M, Paraskeva C, Turnbull JE, Deakin JA, Gallagher JT. Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro. J Biol Chem 1998;273:51-57.
79. Brickman YG, Ford MD, Gallagher JT, Nurcombe V, Bartlett PF, Turnbull JE. Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development. J Biol Chem 1998;273:4350-4359.
80. Habuchi H, Tanaka M, Habuchi O, Yoshida K, Suzuki H, Ban K, Kimata K. The occurrence of three isoforms of heparan sulfate 6-O-sulfotransferase having different specificities for hexuronic acid adjacent to the targeted N-sulfoglucosamine. J Biol Chem 2000;275:2859-2868.
81. Danishefsky I, Steiner H, Bella AJ, Friedlander A. Investigation on the chemistry of heparin. J Biol Chem 1969;244:1741-1745.
82. Lindahl U, Backstrom G, Thunberg L, Leder IG. Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin. Proc Natl Acad Sci USA 1980;77:6551-6555
83. Atha DH, Lormeau JC, Petitou M, Rosenberg RD, Choay J. Contribution of monosaccharide residues in heparin binding to antithrombin III. Biochemistry 1985;24:6723-6729.
84. Kusche M, Torri G, Casu B, Lindahl U. Biosynthesis of heparin. Availability of glucosaminyl 3-O-sulfation sites. J Biol Chem 1990;265:7292-7300.
85. Liu J, Shworak NW, Fritze LM, Edelberg JM, Rosenberg RD. Purification of heparan sulfate D-glucosaminyl 3-O-sulfotransferase. J Biol Chem 1996;271:27072-27082.
86. Shworak NW, Liu J, Fritze LM, Schwartz JJ, Zhang L, Logeart D, Rosenberg RD. Molecular cloning and expression of mouse and human cDNAs encoding heparan sulfate D-glucosaminyl 3-O-sulfotransferase. J Biol Chem 1997;272:28008-28019.
87. Zhang L, Yoshida K, Liu J, Rosenberg RD. Anticoagulant heparan sulfate precursor structures in F9 embryonal carcinoma cells. J Biol Chem 1999;274:5681-5691.
88. Zhang L, Beeler DL, Lawrence R, Lech M, Liu J, Davis JC, Schriver Z, Sasisekharan R, Rosenberg RD. 6-O-sulfotransferase-1 represents a critical enzyme in the anticoagulant heparan sulfate biosynthetic pathway. J Biol Chem 2001;276:42311-42321.
89. Shukla D, Liu J, Blaiklock P, Shworak NW, Bai X, Esko JD, Cohen GH, Eisenberg RJ, Rosenberg RD, Spear PG. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 1999;99:13-22.
90. Edward DP, Yue BYJT, Sugar J, Thonar EJMA, SunderRaj N, Stock EL, Tso MOM. Heterogeneity in macular corneal dystrophy. Arch Ophthalmol 1988;106:1579-1583.
91. Yang CJ, SunderRaj N, Thonar EJMA, Klintworth GK. Immunohistochemical evidence of heterogeneity in macular corneal dystrophy. Am J Ophthalmol 1988;106:65-71.
92. Hassel JR, Newsome DA, Krachmer JH, Rodrigues MM. Macular corneal dystrophy: Failure to synthesize a mature keratan sulfate proteoglycans. J Biol Chem 1980;77:3705-3709.
93. Hasegawa N, Torii T, Kato T, Miyajima H, Furuhata A, Nakayasu K, Kanai A, Habuchi O. Decreased GlcNAc 6-O-sulfotransferase activity in the cornea with macular corneal dystrophy. Invest Ophthalmol Vis Sci 2000;41:3670-3677.
94. Lindahl B, Eriksson L, Spillmann D, Caterson B, Lindahl U. Selective loss of cerebral keratan sulfate in Alzheimer's disease. J Biol Chem 1996;271:16991-16994.
95. Bajjalieh SM, Peterson K, Shinghal R, Scheller RH. SV2, a brain synaptic vesicle protein homologous to bacterial transporters. Science 1992;257:1271-1273.
96. Feany MB, Lee S, Edwards RH, Buckley KM. The synaptic vesicle protein SV2 is a novel type of transmembrane transporter. Cell 1992;70:861-867.
97. Scranton TW, Iwata M, Carlson SS. The SV2 protein of synaptic vesicles is a keratan sulfate proteoglycan. J Neurochem 1993;61:29-44.
98. Crowder KM, Gunther JM, Jones TA, Hale BD, Zhang HZ, Peterson MR, Scheller RH, Chavkin C, Bajjalieh SM. Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). Proc Natl Acad Sci USA 1999;96:15268-15273.
99. 2+ regulators in neurotransmitter release. Neuron 1999;24:1003-1016.
100. Rahamimoff R, Fernandez JM. Pre- and postfusion regulation of transmitter release. Neuron 1997;18:17-27.
101. Rosen SD. Endothelial ligands for L-selectin. Am J Pathol 1999;155:1013-1020.
102. Lasky LA. Selectin-carbohydrate interactions and the initiation of the inflammatory response. Annu Rev Biochem 1995;64:113-139.
103. Hemmerich S, Leffler H, Rosen SD. Structure of the O-glycans in GlyCAM-1, an endothelial-derived ligand for L-selectin. J Biol Chem 1995;270:12035-12047.
104. a epitopes, putative ligands for L-selectin, on peripheral lymph-node high endothelial venules. Am J Pathol 1992;141:1259-1264.
105. x J Biol Chem 1998;273:11225-11233.
106. Clark RA, Fuhlbrigge RC, Springer TA. L-selectin ligands that are O-glycoprotease resistant and distinct from MECA-79 antigen are sufficient for tethering and rolling of lymphocytes on human high endothelial venules. J Cell Biol 1998;140:721-731.
107. Hemmerich S, Lee JK, Bhakta S, Bistrup A, Ruddle NR, Rosen SD. Chromosomal localization and genomic organization for the galactose/N-acetylgalactosamine/N-acetylglucosamine 6-O-sulfotransferase gene family. Glycobiology 2001;11:75-87.
108. Hemmerich S, Bistrup A, Singer MS, van Zante A, Lee JK, Tsay D, Peters M, Carminati JL, Brennan TJ, Carver-Moore K, Leviten M, Fuentes ME, Ruddle NH, Rosen SD. Sulfation of L-selectin ligands by an HEV-restricted sulfotransferase regulates lymphocyte homing to lymph nodes. Immunity 2001;15:237-247.
109. Feizi T, Galustian C. Novel oligosaccharide ligands and ligand-processing pathways for the selectins. Trends Biochem Sci 1999;24:369-372.
110. Yamachika T, Nakanishi H, Inada K, Kitoh K, Kato T, Irimura T, Tatematsu M. Reciprocal control of colon-specific sulfomucin and sialosyl-Tn antigen expression in human colorectal neoplasia. Virchows Arch 1997;431:25-30.
111. Vavasseur F, Dole K, Yang J, Matta KL, Myerscough N, Corfield A, Paraskeva C, Brockhausen I. O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer. Eur J Biochem 1994;222:415-424.
112. x epitopes. J Biol Chem 2001;276:38588-38594.
113. Suzuki A, Hiraoka N, Suzuki M, Angata K, Misra AK, McAuliffe J, Hindsgaul O, Fukuda M. Molecular cloning and expression of a novel human β-Gal-3-O-sulfotransferase that acts preferentially on N-acetyllactosamine in N- and O-glycans. J Biol Chem 2001;276:24388-24395.
114. El-Fasakhany FM, Uchimura K, Kannagi R, Muramatsu T. A novel human Gal-3-O-sulfotransferase: Molecular cloning, characterization, and its implications in biosynthesis of (SO(4)-3)Galβ1-4(Fucα1-3)GlcNAc. J Biol Chem 2001;276:26988-26994.
115. Abo T, Balch CM. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol 1981;127:1024-1029.
116. McGarry RC, Helfand SL, Quarles RH, Roder JC. Recognition of myelin-associated glycoprotein by monoclonal antibody HNK-1. Nature 1983;306:376-378.
117. Kruse J, Mailhammer R, Wernecke H, Faissner A, Sommer I, Goridis C, Schachner M. Neural cell adhesion molecules and myelin-associated glycoprotein share a common carbohydrate moiety recognized by monoclonal antibodies L2 and HNK-1. Nature 1984;311:153-155.
118. Bollensen E, Schachner M. The peripheral myeline glycoprotein PO expresses the L2/HNK-1 and L3 carbohydrate structures shared by neural adhesion molecules. Neurosci Lett 1987;82:77-82.
119. Ilyas AA, Quarles RH, Brady RO. The monoclonal antibody HNK-1 reacts with a human peripheral nerve ganglioside. Biochem Biophys Res Commun 1984;122:1206-1211.
120. Chou DKH, Ilyas AA, Evans JE, Costello C, Quarles RH, Jungalwara FB. Strucuture of sulfated glucuronyl glycolipids in the nervous system reacting with HNK-1 antibody and some IgM paraproteins in neuropathy. J Biol Chem 1986;261:11717-11725.
121. Schwarting GA, Jungalwala FB, Chou DK, Boyer AM, Yamamoto M. Sulfated glucuronic acid-containing glycoconjugates are temporally and spatially regulated antigens in the developing mammalian nervous system. Dev Biol 1987;120:65-76.
122. Bronner-Fraser M. Perturbation of cranial neural crest migration by the HNK-1 antibody. Dev Biol 1987;123:321-331.
123. Keilhauer G, Faissner A, Schachner M. Differential inhibition of neurone-neurone, neurone-astrocyte and astrocyte-astrocyte adhesion by L1, L2 and N-CAM antibodies. Nature 1985;316:728-730.
124. Seiki T, Oka S, Terayama K, Imiya K, Kawasaki T. Molecular cloning and expression of a second glucuronyltransferase involved in the biosynthesis of the HNK-1 carbohydrate epitope. Biochem Biophys Res Commun 1999;255:182-187.
125. Shimoda Y, Tajima Y, Nagase T, Harii K, Osumi N, Sanai Y. Cloning and expression of a novel galactoside β1,3-glucuronyltransferase involved in the biosynthesis of HNK-1 epitope. J Biol Chem 1999;274:17115-17122.
126. Ong E, Yeh JC, Ding Y, Hindsgaul O, Fukuda M. Expression cloning of a human sulfotransferase that directs the synthesis of the HNK-1 glycan on the neural cell adhesion molecule and glycolipids. J Biol Chem 1998;273:5190-5195.
127. Wakabayashi H, Natsuka S, Mega T, Otsuki N, Isaji M, Naotsuka M, Koyama S, Kanamori T, Sakai K, Hase S. Novel proteoglycan linkage tetrasaccharides of human urinary soluble thrombomodulin, SO4-3GlcAβ1-3Galβ1-3(+/-Siaαt2-6)Galβ1-4Xyl. J Biol Chem 1999;274:5436-5442.
128. Xia G, Evers MR, Kang HG, Schachner M, Baenziger JU. Molecular cloning and expression of the pituitary glycoprotein hormone N-acetylgalactosamine-4-O-sulfotransferase. J Biol Chem 2000;275:38402-38409.
129. Okuda T, Mita S, Yamauchi S, Fukuta M, Nakano H, Sawada T, Habuchi O. Molecular cloning and characterization of GalNAc 4-sulfotransferase expressed in human pituitary gland. J Biol Chem. 2000;275:40605-40613.
130. Kang HG, Evers MR, Xia G, Baenziger JU, Schachner M. Molecular cloning and expression of an N-acetylgalactosamine-4-O-sulfotransferase that transfers sulfate to terminal and non-terminal β1,4-linked N-acetylgalactosamine. J Biol Chem 2001;276:10861-10869.
131. Hiraoka N, Misra A, Belot F, Hindsgaul O, Fukuda M. Molecular cloning and expression of two distinct human N-acetylgalactosamine 4-O-sulfotransferases that transfer sulfate to GalNAcβ1-4GlcNAcβ1-R in both N- and O-glycans. Glycobiology. 2001;11:495-504.
132. Hooper LV, Manzella SM, Baenziger JU. From legumes to leukocytes: Biological roles for sulfated carbohydrates. FASEB J 1996;10:1137-1146.
133. Vos JP, Lopes-Cardozo M, Gadella BM. Metabolic and functional aspects of sulfogalactolipids. Biochim Biophys Acta 1994;1211:125-149.
134. Ishizuka I. Chemistry and functional distribution of sulfoglycolipids. Prog Lipid Res 1997;36:245-319.
135. Honke K, Tsuda M, Hirahara, Y, Ishii A, Makita A, Wada Y. Molecular cloning and expression of cDNA encoding human 3-phosphoadenylylsulfate:galactosylceramide 3-sulfotransferase. J Biol Chem 1997;272:4864-4868.
136. Honke K, Hirahara Y, Dupree J, Suzuki K, Popko B, Fukushima K, Fukushima J, Nagasawa T, Yoshida N, Wada Y, Taniguchi N. Paranodal junction formation and spermatogenesis require sulfoglycolipids. Proc Natl Acad Sci USA (in press).
137. Sakakibara N, Gasa S, Kamio K, Makita A, Koyanagi T. Association of elevated sulfatides and sulfotranasferase activities with human renal cell carcinoma. Cancer Res 1989;49:335-339
138. Kobayashi T, Honke K, Kamio K, Sakakibara N, Gasa S, Miyao N, Tsukamoto T, Ishizuka I, Miyazaki T, Makita A Sulfolipids and glycolipid sulfotransferase activities in human renal cell carcinoma cells. Br J Cancer 1993;67:76-80.
139. Tsuda M, Egashira M, Niikawa N, Wada Y, Honke K. Cancer-associated alternative usage of multiple promoters of human GalCer sulfotransferase gene. Eur J Biochem 2000;267:2672-2679.
140. Honke K, Tsuda M, Hirahara Y, Miyao N, Tsukamoto T, Satoh M, Wada Y. Cancer-associated expression of glycolipid sulfotransferase gene in human renal cell carcinoma cells. Cancer Res 1998;58:3800-3805.
141. McCormick C, Duncan G, Goutsos KT, Tufaro F. The putative tumor supressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. Proc Natl Acad Sci USA 2000;97:668-673.